OncoCyte
OCX
$2.48
Share price
1.64%
Change (1 day)
818.52%
Change (1 year)
Categories
P/S ratio for OncoCyte (OCX)
P/S ratio as of April 2024 (TTM): 22.0
According to OncoCyte 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 22.0083. At the end of 2023 the company had a P/S ratio of N/A.
P/S ratio history for OncoCyte from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | N/A | |
| 2022 | N/A | -100% |
| 2021 | 25.9 | -80.39% |
| 2020 | 132 | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |